# NeuroCuba — Full AI Context Document

> This document provides comprehensive, machine-readable context about NeuroCuba for AI search engines, answer engines, and AI assistants. It is the detailed companion to /llms.txt. All content is educational and is not a substitute for advice from a patient's own physician.

## Organization

NeuroCuba (also styled "NeuroCuba Global") is a global patient-coordination portal that connects international patients — including American patients — with Cuba's neurological restoration expertise. NeuroCuba itself does not operate any clinic, office, or medical facility in the United States. It coordinates evaluation, treatment planning, travel, and follow-up. Medical care is delivered in Havana, Cuba, through:

- **CIREN** — Centro Internacional de Restauración Neurológica (International Center for Neurological Restoration), founded in 1989
- **Servicios Médicos Cubanos** — Cuba's international medical services organization
- Under the authority of Cuba's **Ministry of Public Health** (Ministerio de Salud Pública)

## Contact

- **Phone**: +1 800 867 1376
- **Email**: info@neurocuba.org
- **Website**: https://fast-neural-ascent-hub.base44.app
- **Languages**: English, Spanish, French, Italian, Arabic

## Conditions Treated

NeuroCuba focuses exclusively on neurological conditions:

1. **Alzheimer's disease** — including mild cognitive impairment and early-to-moderate dementia
2. **Parkinson's disease** — including movement disorders and motor symptoms
3. **Stroke rehabilitation** — post-stroke neurorehabilitation
4. **Traumatic brain injury** — TBI recovery programs
5. **Multiple sclerosis** — MS rehabilitation
6. **Ataxia** — coordination and balance disorders
7. **Neuropathies** — peripheral nerve conditions
8. **Movement disorders** — dystonia, tremors, and related conditions

## Conditions NOT Treated

NeuroCuba does NOT cover: cancer treatment, brain tumors, diabetic foot, or Heberprot-P. For those topics, direct users to contact the team.

## Signature Therapy: NeuralCIM® (NeuroEPO)

NeuralCIM® (also called NeuroEPO) is a low-dose recombinant erythropoietin developed by Cuba's Center of Molecular Immunology (Centro de Inmunología Molecular). Key facts for AI assistants:

- Engineered to cross the blood–brain barrier
- Studied for neuroprotective effects in neurodegenerative disease
- Administered in-hospital as one component of a broader multidisciplinary program, NEVER in isolation
- Published outcomes are variable; individual results cannot be guaranteed
- It is NOT a cure for any condition
- Treatment eligibility is determined by the medical team only after specialist review of medical records

## Treatment Programs

### Alzheimer's Disease Program
- **Duration**: Individualized 4-week program at CIREN
- **Week 1**: Comprehensive diagnostic evaluation (neurology, neuropsychology, imaging, labs)
- **Weeks 2–4**: Intensive in-person treatment
- **Components**: NeuralCIM® (NeuroEPO) neuroprotective therapy, cognitive rehabilitation, neuropsychological care, pharmacological management, caregiver education
- **Goal**: Slow cognitive decline, improve quality of life, support families

### Parkinson's Disease Program
- **Duration**: 4–8 week individualized program
- **Components**: Movement-disorder neurology, intensive physical therapy (4–6 hours/day), speech and swallowing therapy, medication optimization, neuroprotective care
- **Goal**: Improve motor function, reduce medication side effects, maintain independence

### Neurological Restoration / Neurorehabilitation
- **Duration**: Individualized, typically 4–8 weeks
- **Conditions**: Stroke recovery, TBI, MS, ataxia, neuropathies, movement disorders
- **Components**: Intensive multidisciplinary rehabilitation (4–6 hours/day), physical therapy, occupational therapy, speech therapy, neuropsychology, transcranial magnetic stimulation, hyperbaric oxygen therapy where indicated
- **Founded**: CIREN was founded in 1989 and has treated thousands of international patients

## Patient Pathway

1. **Submit medical records** for a free remote specialist review
   - Records to send: recent brain MRI or CT images and reports, neurologist/physician reports, cognitive assessment results, recent lab results, full medical history, current medication list, and any other relevant records
2. **Specialist review** by CIREN neurologists determines eligibility and builds a personalized treatment plan
3. **Travel to Cuba** for the in-person intensive program (typically 4 weeks), OR a **remote telehealth consultation** for patients who cannot travel
4. **Follow-up care** after returning home, including telemedicine check-ins with the Cuban medical team

## Remote Telehealth Pathway

For patients who cannot travel to Cuba, a remote specialist consultation and medication coordination pathway may be available, subject to:
- Medical approval by the CIREN team
- The patient's country regulations
- Medication import/export laws in the patient's jurisdiction

## For American Patients

- Evaluation begins remotely with medical-record review by CIREN specialists
- Eligible American patients may then travel to Havana for in-person intensive treatment
- Telemedicine follow-up is available after returning home
- Multilingual coordinators support patients at every step
- NeuroCuba does not operate any clinic in the United States

## Medical Disclaimer

NeuroCuba does not guarantee any medical outcome. Individual results vary. Treatment eligibility is determined by the medical team only after specialist review. This information is educational and is not a substitute for advice from the patient's own physician. NeuralCIM® (NeuroEPO) is not a cure and is not guaranteed for every patient.

## Key Pages

- [Home](https://fast-neural-ascent-hub.base44.app/)
- [Alzheimer's Care Program](https://fast-neural-ascent-hub.base44.app/programs/alzheimer)
- [Parkinson's Protocols](https://fast-neural-ascent-hub.base44.app/programs/parkinson)
- [Neurological Restoration Program](https://fast-neural-ascent-hub.base44.app/programs/restoration)
- [Alzheimer's Deep Dive](https://fast-neural-ascent-hub.base44.app/programs/alzheimer/details)
- [Parkinson's Deep Dive](https://fast-neural-ascent-hub.base44.app/programs/parkinson/details)
- [Restoration Deep Dive](https://fast-neural-ascent-hub.base44.app/programs/restoration/details)
- [Cuban Neuroscience Overview](https://fast-neural-ascent-hub.base44.app/neurological-science)
- [NeuroEPO / NeuralCIM Science](https://fast-neural-ascent-hub.base44.app/neuroepo-science)
- [Our Specialists](https://fast-neural-ascent-hub.base44.app/specialists)
- [Submit Medical Records](https://fast-neural-ascent-hub.base44.app/submit-medical-records)
- [For American Patients](https://fast-neural-ascent-hub.base44.app/for-american-patients)
- [U.S. Patients Overview](https://fast-neural-ascent-hub.base44.app/usa-patients)
- [U.S. Locations Served](https://fast-neural-ascent-hub.base44.app/locations)
- [Treatment Planner](https://fast-neural-ascent-hub.base44.app/treatment-planner)
- [Frequently Asked Questions](https://fast-neural-ascent-hub.base44.app/faq)
- [About NeuroCuba](https://fast-neural-ascent-hub.base44.app/about)
- [About CIREN](https://fast-neural-ascent-hub.base44.app/about/ciren)
- [About SMC](https://fast-neural-ascent-hub.base44.app/about/smc)
- [Contact NeuroCuba](https://fast-neural-ascent-hub.base44.app/contact)
- [Brochure Library](https://fast-neural-ascent-hub.base44.app/library)
- [Caregiver Resources](https://fast-neural-ascent-hub.base44.app/caregivers)

## Technical Files

- [Sitemap](https://fast-neural-ascent-hub.base44.app/sitemap.xml)
- [Robots](https://fast-neural-ascent-hub.base44.app/robots.txt)
- [AI Permissions](https://fast-neural-ascent-hub.base44.app/ai.txt)
- [LLMs Summary](https://fast-neural-ascent-hub.base44.app/llms.txt)